| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |